Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: hoyasaxa who wrote (15736)	12/2/2002 5:28:45 PM
From: Paul Senior	Respond to of 78625

hoyasaxa, looked at LH once again. And again, it's still to tough for me to figure. According to scuttlebutt from Yahoo, LH has is partnered with a small company that has or is about to have or may have a very significant cancer diagnostic test. I read the latest issue of Money mag. which has a positive write up on LH. On the negative side, an analyst has apparently indicated that more hospitals are increasing the amount of in-house testing they will be doing (reducing need for LH services). Back on that other hand, five of 14 analysts have a buy on the stock, and with a p/e of 12 on next year's expected earnings, that seems reasonable, esp. if an acquisition or two kicks in. Margins look high now; in past years they have fluctuated quite a bit. Upshot for me: I'd say the stock might very well go higher, but I can't figure if the odds are in my favor at current price or not. So I'll pass again. finance.yahoo.com Anybody else here with an assessment of this company/stock?

To: hoyasaxa who wrote (15736)	1/7/2003 2:33:25 PM
From: Paul Senior	Read Replies (1) \| Respond to of 78625

fwiw: hoyasaxa, I'll take on a very small exploratory position in LH now. LH would seem to provide a necessary service, one that grows with complexity of medical procedures. I agree that company has "impressively performed" in recent years. And p/e is reasonable if business continues and company can continue bottom line performance. At this time though, I still don't understand LH's business strategy or how government reimbursement policies might or might not affect LH business. If the key is to monitor LH pricing and volume trends, I am hoping I will see that show in operating and profit margins - numbers which are more readily available to me. If pricing/vol numbers worsen, I will have to hope I catch and react to margin degradation before the stock drops. I still like CRO's QTRN and KNDL and am unprofitably holding small positions there. finance.yahoo.com